You just read:

Viking Therapeutics Announces Positive Top-Line Results from Proof-of-Concept Study of VK0214 in In Vivo Model of X-Linked Adrenoleukodystrophy (X-ALD)

News provided by

Viking Therapeutics, Inc

Jul 26, 2016, 07:03 ET